Literature DB >> 8967985

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.

E V Varga1, X Li, D Stropova, T Zalewska, R S Landsman, R J Knapp, E Malatynska, K Kawai, A Mizusura, H Nagase, S N Calderon, K Rice, V J Hruby, W R Roeske, H I Yamamura.   

Abstract

In the present study, we replaced the third extracellular loop of the human delta-opioid receptor with that of the human mu-opioid receptor. A modified polymerase chain reaction overlap extension method was used to achieve the exact splicing in the chimera to show the importance of the extracellular loop in ligand binding without interference from transmembrane substitutions. The replacement of the third extracellular loop did not alter the affinity of [3H]diprenorphine but caused a dramatic decrease in the affinity of both the delta-selective peptide agonists cyclo[D-Pen2,4'Cl-Phe4,D-Pen5]enkephalin and deltorphin II and the delta-selective nonpeptide agonists SNC 121 and (-)TAN 67. The affinities of the mu-selective peptide agonist [D-Ala2-MePhe4-Gly-ol5]enkephalin and the mu-preferring nonpeptide agonist morphine were not affected. Site-directed mutagenesis studies show that the mechanism of ligand recognition might be different for each structural class of opioid ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967985

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

2.  Controlling signaling with a specifically designed Gi-coupled receptor.

Authors:  P Coward; H G Wada; M S Falk; S D Chan; F Meng; H Akil; B R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction.

Authors:  Leonid N Maslov; Yury B Lishmanov; Peter R Oeltgen; Eva I Barzakh; Andrey V Krylatov; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown
Journal:  Acad Emerg Med       Date:  2010-11       Impact factor: 3.451

4.  Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.

Authors:  S Allouche; J Polastron; A Hasbi; V Homburger; P Jauzac
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

Review 5.  Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons.

Authors:  Xu Zhang; Lan Bao
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

6.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

Authors:  I D Pogozheva; A L Lomize; H I Mosberg
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

Review 7.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

Review 8.  Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors.

Authors:  Yazan J Meqbil; Richard M van Rijn
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.